eFFECTOR(EFTR) - 2024 Q1 - Quarterly Report
eFFECTOReFFECTOR(US:EFTR)2024-05-09 20:03

WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39866 eFFECTOR Therapeutics, Inc. (Exact name of Registrant as specified in its Charter) Delaware 85-3306396 (State or other juri ...